Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System
With a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this webinar, part of our Infectious Disease Webinar Series, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection.
Publish Date:
August 18, 2020
Related Multimedia
-
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation
Publish Date: April 20, 2016 -
STEMCELL Journal Club: Cerebral Organoids for Human-Specific Infection Modeling
Publish Date: May 25, 2020
Explore Our Products
-
Anti-SARS-CoV Spike Protein S1 Receptor-Binding Domain Antibody, Clone D005 (Recombinant)
Chimeric mouse (V), human (C) monoclonal IgG antibody against SARS-CoV, SARS-CoV-2 (2019-nCoV) S protein (HEK293-expressed recombinant) -
SARS-CoV-2 Recombinant Nucleocapsid Protein, aa1-419 (E. coli-expressed)
Novel coronavirus (SARS-CoV-2/ 2019-nCoV) nucleocapsid protein (recombinant), amino acids Met1-Ala419, His & T7 tags -
SARS-CoV-2 Recombinant Spike Protein, aa319-541 (Yeast-expressed)
SARS-CoV-2 recombinant spike protein, amino acids Arg319-Phe541, His tag -
Anti-SARS-CoV Nucleoprotein Antibody, Clone 001 (Recombinant)
Rabbit monoclonal IgG antibody against SARS-CoV, SARS-CoV-2 (2019-nCoV) Nucleoprotein (HEK293-expressed recombinant)
